总时间（秒）：25.69
问答时间（秒）：22.81

{
    "functional_evidence_assessment": [
        {
            "variant_id": {
                "Gene": "Alpha-Synuclein",
                "Protein_Change": {
                    "ref": "WT",
                    "alt": "",
                    "position": ""
                },
                "variant_string_id": "Alpha-Synuclein WT"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper discusses how increased levels of wild-type R-synuclein are associated with Parkinson’s disease, a disease linked to abnormal mitochondrial function.",
                    "judgment": "Yes",
                    "reasoning": "Increased levels of the wild-type protein (WT) are implicated in Parkinson's disease, and this study aims to examine its effects on the mitochondrial proteome."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study compares mitochondria prepared from differentiated SH-SY5Y cells overexpressing WT R-synuclein with control cells using 2D-difference in-gel electrophoresis (2D-DIGE), a technique used to compare proteins between two samples.",
                    "judgment": "Yes",
                    "reasoning": "2D-DIGE is a widely accepted and validated method for comparing proteomes, and it effectively models the disease pathogenesis by examining changes in mitochondrial proteins, which are known to be affected in Parkinson's disease."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "sub_steps": [
                        {
                            "sub_step_name": "3a. Basic Controls and Replicates",
                            "questions": [
                                {
                                    "question": "Were basic controls included for this assay? Specifically, were *both* 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                                    "answer": "Yes"
                                },
                                {
                                    "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                                    "answer": "Yes"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "3c. Variant Controls",
                            "questions": [
                                {
                                    "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?",
                                    "answer": "Not explicitly stated"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "4a. Statistical Analyses",
                            "questions": [
                                {
                                    "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                                    "answer": "Yes"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "4b. No OddsPath Calculation (if statistical analyses were insufficient)",
                            "questions": []
                        },
                        {
                            "sub_step_name": "4c. Correlate OddsPath (if statistical analyses were sufficient)",
                            "questions": [
                                {
                                    "question": "How many total benign/pathogenic variant controls were used across the entire study?",
                                    "answer": "Not explicitly stated"
                                }
                            ]
                        }
                    ]
                }
            ],
            "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
        },
        {
            "variant_id": {
                "Gene": "Alpha-Synuclein",
                "Protein_Change": {
                    "ref": "",
                    "alt": "mutant",
                    "position": ""
                },
                "variant_string_id": "Alpha-Synuclein mutant"
            },
            "functional_evidence_aim": "Pathogenic",
            "assessment_steps": [
                {
                    "step_name": "Step 1: Define the disease mechanism",
                    "extracted_paper_info": "The paper discusses how increased levels of wild-type R-synuclein are associated with Parkinson’s disease, a disease linked to abnormal mitochondrial function.",
                    "judgment": "Yes",
                    "reasoning": "Increased levels of the mutant protein (mutant) are implicated in Parkinson's disease, and this study aims to examine its effects on the mitochondrial proteome."
                },
                {
                    "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
                    "extracted_paper_info": "The study compares mitochondria prepared from differentiated SH-SY5Y cells overexpressing mutant R-synuclein with control cells using 2D-difference in-gel electrophoresis (2D-DIGE), a technique used to compare proteomes between two samples.",
                    "judgment": "Yes",
                    "reasoning": "2D-DIGE is a widely accepted and validated method for comparing proteomes, and it effectively models the disease pathogenesis by examining changes in mitochondrial proteins, which are known to be affected in Parkinson's disease."
                },
                {
                    "step_name": "Step 3: Evaluate validity of specific instances of assays",
                    "sub_steps": [
                        {
                            "sub_step_name": "3a. Basic Controls and Replicates",
                            "questions": [
                                {
                                    "question": "Were basic controls included for this assay? Specifically, were *both* 'Normal/Negative/Wild type' AND 'Abnormal/Positive/Null' controls used?",
                                    "answer": "Yes"
                                },
                                {
                                    "question": "Did the paper explicitly state that multiple replicates were used for the experiments?",
                                    "answer": "Yes"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "3c. Variant Controls",
                            "questions": [
                                {
                                    "question": "Were variant controls used in the assay for this variant? Specifically, were known pathogenic variants used as controls?",
                                    "answer": "Not explicitly stated"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "4a. Statistical Analyses",
                            "questions": [
                                {
                                    "question": "Are the statistical analyses in the paper sufficient to estimate or calculate OddsPath for the functional data for this variant?",
                                    "answer": "Yes"
                                }
                            ]
                        },
                        {
                            "sub_step_name": "4b. No OddsPath Calculation (if statistical analyses were insufficient)",
                            "questions": []
                        },
                        {
                            "sub_step_name": "4c. Correlate OddsPath (if statistical analyses were sufficient)",
                            "questions": [
                                {
                                    "question": "How many total benign/pathogenic variant controls were used across the entire study?",
                                    "answer": "Not explicitly stated"
                                }
                            ]
                        }
                    ]
                }
            ],
            "functional_evidence_strength": "Max PS3_supporting / Max BS3_supporting"
        }
    ]
}